{"id":54027,"date":"2023-02-16T22:06:31","date_gmt":"2023-02-16T21:06:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"modified":"2023-02-16T22:06:31","modified_gmt":"2023-02-16T21:06:31","slug":"correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","title":{"rendered":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023"},"content":{"rendered":"<div>\n<p>SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/5\/01_omnicell_lockup_horizontal_green_rgb.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg\"><\/a><\/p>\n<p>\nThe updated release reads:\n<\/p>\n<p class=\"bwalignc\">\n<b>OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023<\/b>\n<\/p>\n<p>\nOmnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.\n<\/p>\n<p>\nAll interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.omnicell.com%2Fevents-and-presentations%2F&amp;esheet=53328672&amp;newsitemid=20230215005901&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.omnicell.com%2Fevents-and-presentations%2F&amp;index=1&amp;md5=df7461bb03620f83d6561062dcfdee12\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.omnicell.com\/events-and-presentations\/<\/a>.\n<\/p>\n<p>\n<b>About Omnicell<\/b>\n<\/p>\n<p>\nSince 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Healthcare facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell&#8217;s innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.omnicell.com&amp;esheet=53328672&amp;newsitemid=20230215005901&amp;lan=en-US&amp;anchor=www.omnicell.com&amp;index=2&amp;md5=9a295b325170052c26170fffb8e4a6fe\" rel=\"nofollow noopener\" shape=\"rect\">www.omnicell.com<\/a>.\n<\/p>\n<p>\nOMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.\n<\/p>\n<p>\nOMCL-E\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nKathleen Nemeth<br \/>\n<br \/>Senior Vice President, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;i&#114;&#x40;&#111;&#x6d;n&#105;&#x63;e&#x6c;l&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x72;&#64;&#x6f;m&#110;&#x69;&#99;&#x65;l&#108;&#x2e;&#99;&#x6f;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023 Omnicell, Inc. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54027","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023 Omnicell, Inc. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T21:06:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023\",\"datePublished\":\"2023-02-16T21:06:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"},\"wordCount\":321,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\",\"name\":\"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"datePublished\":\"2023-02-16T21:06:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230215005901\\\/en\\\/770780\\\/21\\\/01_omnicell_lockup_horizontal_green_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","og_description":"SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023 Omnicell, Inc. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-16T21:06:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023","datePublished":"2023-02-16T21:06:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"},"wordCount":321,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/","name":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","datePublished":"2023-02-16T21:06:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230215005901\/en\/770780\/21\/01_omnicell_lockup_horizontal_green_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-omnicell-to-release-fourth-quarter-and-full-year-2022-financial-results-on-february-28-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING Omnicell to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54027"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54027\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}